Antibody response to influenza immunization in kidney transplant recipients receiving either azathioprine or mycophenolate: A controlled trial

American Journal of Nephrology

Volumn 28, Issue 4, 2008, Pages 654-660

  Keshtkar Jahromi, Maryam ^a   Argani, Hassan ^b,c   Rahnavardi, Mohammad ^a   Mirchi, Elham ^c   Atabak, Shahnaz ^c   Tara, Seied Ahmad ^c   Gachkar, Latif ^a   Noori Froothghe, Azam ^c   Mokhtari Azad, Talat ^d  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antibody response; Azathioprine; Immunization; Influenza; Kidney transplant recipient; Mycophenolate mofetil; Vaccination

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; INFLUENZA VACCINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GRAFT RECIPIENT; HUMAN; HUMORAL IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA; INFLUENZA VACCINATION; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; MALE; PRIORITY JOURNAL; SEROLOGY; SIDE EFFECT;

ADULT; ANTIBODIES, VIRAL; ANTIBODY FORMATION; AZATHIOPRINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLUENZA VACCINES; KIDNEY TRANSPLANTATION; MALE; MYCOPHENOLIC ACID; VACCINATION;

EID: 45149089620     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000119742     Document Type: Article

References (33)

1. Brundage JF: Cases and deaths during influenza pandemics in the United States. Am J Prev Med 2006;31:252-256.
2. Lin JC, Nichol KL: Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome. Arch Intern Med 2001;161:441-446.
3. Maciosek MV, Solberg LI, Coffield AB, Edwards NM, Goodman MJ: Influenza vaccination health impact and cost effectiveness among adults aged 50-64 and 65 and older. Am J Prev Med 2006;31:72-79.
4. Vilchez RA, Fung J, Kusne S: The pathogenesis and management of influenza virus infection in organ transplant recipients. Transpl Infect Dis 2002;4:177-182.
5. Ballout A, Goffin E, Yombi JC, Vandercam B: Vaccinations for adult solid organ transplant recipient: current recommendations. Transplant Proc 2005;37:2826-2827.
6. Mauch TJ, Crouch NA, Freese DK, Braunlin EA, Dunn DL, Kashtan CE: Antibody response of pediatric solid organ transplant recipients to immunization against influenza virus. J Pediatr 1995;127:957-960.
7. Carroll RN, Marsh SD, O'Donoghue EP, Breeze DC, Shackman R: Response to influenza vaccine by renal transplant patients. Br Med J 1974;2:701-703.
8. Pabico RC, Douglas RG, Betts RF, McKenna BA, Freeman RB: Antibody response to influenza vaccination in renal transplant patients: correlation with allograft function. Ann Intern Med 1976;85:431-436.
9. Stiver HG, Graves P, Meiklejohn G, Schroter G, Eickhoff TC: Impaired serum antibody response to inactivated influenza A and B vaccine in renal transplant recipients. Infect Immun 1977;16:738-741.
10. Kumar SS, Ventura AK, VanderWerf B: Influenza vaccination in renal transplant recipients. JAMA 1978;239:840-842.
11. Hodges GR, Davis JW, Lewis HD Jr, Whittier FC Jr, Siegel CD, Chin TD, Clark GM, Noble GR: Response to influenza A vaccine among high-risk patients. South Med J 1979;72:29-32.
12. Briggs WA, Rozek RJ, Migdal SD, Shillis JL, Brackett RG, Brandon FB, Mahajan SK, McDonald FD: Influenza vaccination in kidney transplant recipients: cellular and humoral immune responses. Ann Intern Med 1980;92:471-477.
13. Huang KL, Armstrong JA, Ho M: Antibody response after influenza immunization in renal transplant patients receiving cyclosporin A or azathioprine. Infect Immun 1983;40:421-424.
14. Powers RD, Hayden FG, Samuelson J, Gwaltney JM: Immune response of adults to sequential influenza vaccination. J Med Virol 1984;14:169-175.
15. Versluis DJ, Beyer WE, Masurel N, Wenting GJ, Weimar W: Impairment of the immune response to influenza vaccination in renal transplant recipients by cyclosporine, but not azathioprine. Transplantation 1986;42:376-379.
16. Grekas D, Alivanis P, Kiriazopoulou V, Dioudis C, Sioulis A, Derveniotis V, Tourkantonis A: Influenza vaccination on renal transplant patients is safe and serologically effective. Int J Clin Pharmacol Ther Toxicol 1993;31:553-556.
17. Edvardsson VO, Flynn JT, Deforest A, Kaiser BA, Schulman SL, Bradley A, Palmer J, Polinsky MS, Baluarte HJ: Effective immunization against influenza in pediatric renal transplant recipients. Clin Transplant 1996;10:556-560.
18. Smith KG, Isbel NM, Catton MG, Leydon JA, Becker GJ, Walker RG: Suppression of the humoral immune response by mycophenolate mofetil. Nephrol Dial Transplant 1998;13:160-164.
19. Sanchez-Fructuoso AI, Prats D, Naranjo P, Fernandez-Perez C, Gonzalez MJ, Mariano A, Gonzalez J, Figueredo MA, Martin JM, Paniagua V, Fereres J, Gomez de la Concha E, Barrientos A: Influenza virus immunization effectivity in kidney transplant patients subjected to two different triple-drug therapy immunosuppression protocols: mycophenolate versus azathioprine. Transplantation 2000;69:436-439.
20. Wyzgal J, Brydak LB, Zygier D, Paczek L, Rowinski W, Grochowiecki T: Study on efficacy of influenza vaccination in renal allograft recipients. Transplant Proc 2002;34:572-575.
21. Cavdar C, Sayan M, Sifil A, Artuk C, Yilmaz N, Bahar H, Camsari T: The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients. Scand J Urol Nephrol 2003;37:71-76.
22. Lindemann M, Witzke O, Lutkes P, Fiedler M, Kreuzfelder E, Philipp T, Roggendorf M, Grosse-Wilde H: ELISpot assay as a sensitive tool to detect cellular immunity following influenza vaccination in kidney transplant recipients. Clin Immunol 2006;120:342-348.
23. Allison AC: Mechanisms of action of mycophenolate mofetil. Lupus 2005;14:S2-S8.
24. Lambkin R, Novelli P, Oxford J, Gelder C: Human genetics and responses to influenza vaccination: clinical implications. Am J Pharmacogenomics 2004;4:293-298.
25. WHO Collaborating Center for Influenza, Biological Products Division: The Hemagglutination Inhibition Test for Influenza Viruses. Verson 31 revised, DHEW, PHS, CDC. Atlanta, Center for Infectious Disease, 1981, pp 1-21.
26. Kunin CM, Schwartz R, Yaffe S, Knapp J, Fellers FX, Janeway CA, Finland M: Antibody response to influenza-virus vaccine in children with nephrosis: effect of cortisone. Pediatrics 1959;23:54-62.
27. Brodman R, Gilfillan R, Glass D, Schur PH: Influenzal vaccine response in systemic lupus erythematosus. Ann Intern Med 1978;88:735-740.
28. Herron A, Dettleff G, Hixon B, Brandwin L, Ortbals D, Hornick R, Hahn B: Influenza vaccination in patients with rheumatic diseases. Safety and efficacy. JAMA 1979;242:53-56.
29. Van den Wall Bake AW, Beyer WE, Evers-Schouten JH, Hermans J, Daha MR, Masurel N, van Es LA: Humoral immune response to influenza vaccination in patients with primary immunoglobulin A nephropathy. An analysis of isotype distribution and size of the influenza-specific antibodies. J Clin Invest 1989;84:1070-1075.
30. Yanai-Berar N, Ben-Itzhak O, Gree J, Nakhoul F: Influenza vaccination induced leukocytoclastic vasculitis and pauci-immune crescentic glomerulonephritis. Clin Nephrol 2002;58:220-223.
31. Kao CD, Chen JT, Lin KP, Shan DE, Wu ZA, Liao KK: Guillain-Barré syndrome coexisting with pericarditis or nephrotic syndrome after influenza vaccination. Clin Neurol Neurosurg 2004;106:136-138.
32. Kielstein JT, Termühlen L, Sohn J, Kliem V: Minimal change nephrotic syndrome in a 65-year-old patient following influenza vaccination. Clin Nephrol 2000;54:246-248.
33. Raman KS, Chandrasekar T, Reeve RS, Roberts ME, Kalra PA: Influenza vaccine-induced rhabdomyolysis leading to acute renal transplant dysfunction. Nephrol Dial Transplant 2006;21:530-531.